Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 15,962,000 | 15,035,000 | 14,487,000 | 13,830,000 | 14,959,000 |
| Cost of Goods | 4,264,000 | 4,024,000 | 3,926,000 | 3,881,000 | 3,934,000 |
| Gross Profit | 11,698,000 | 11,011,000 | 10,561,000 | 9,949,000 | 11,025,000 |
| Operating Expenses | 5,826,000 | 16,023,000 | 6,755,000 | 6,462,000 | 6,919,000 |
| Operating Income | 5,872,000 | -5,012,000 | 3,806,000 | 3,487,000 | 4,106,000 |
| Other Income | -252,000 | -323,000 | -156,000 | 26,000 | -523,000 |
| Pre-tax Income | 5,620,000 | -5,335,000 | 3,650,000 | 3,513,000 | 3,583,000 |
| Income Tax | 870,000 | 637,000 | 825,000 | 496,000 | 330,000 |
| Net Income Continuous | 4,750,000 | -5,972,000 | 2,825,000 | 3,017,000 | 3,253,000 |
| Minority Interests | 5,000 | 3,000 | 4,000 | N/A | 5,000 |
| Net Income | $4,745,000 | $-5,975,000 | $2,821,000 | $3,017,000 | $3,248,000 |
| EPS Basic Total Ops | 1.87 | -2.35 | 1.11 | 1.19 | 1.28 |
| EPS Basic Continuous Ops | 1.87 | -2.35 | 1.11 | 1.19 | 1.28 |
| EPS Diluted Total Ops | 1.86 | -2.35 | 1.11 | 1.18 | 1.28 |
| EPS Diluted Continuous Ops | 1.87 | -2.35 | 1.11 | 1.18 | 1.28 |
| EBITDA(a) | $6,886,000 | $-4,109,000 | $4,797,000 | $4,379,000 | $5,065,000 |